Evaluation of therapeutic efficacy of Majoon Suranjan, a Unani formulation, in the treatment of rheumatoid arthritis: An experimental study

Experimental Biology and Medicine

Volumn 238, Issue 12, 2013, Pages 1379-1387

  Subramaneyaan, Mythily ^a   Yasmeen, Shagufta ^a   Ahmed, Rafat S ^a   Arora, Vinod K ^a   Tripathi, Asok K ^a   Banerjee, Basu D ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

autoimmune disease; collagen induced arthritis; Majoon Suranjan; methotrexate; rheumatoid arthritis; traditional medicine; Unani system of medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; COLLAGEN TYPE 2; CREATININE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HEMOGLOBIN; HERBACEOUS AGENT; MAJOON SURANJAN; METHOTREXATE; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; UREA;

ACUTE TOXICITY; ALTERNATIVE MEDICINE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; FOOT PAD; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; KUPFFER CELL; LIMB SWELLING; LIVER SINUSOID; LYMPHOCYTE COUNT; MALE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS;

AUTOIMMUNE DISEASE; COLLAGEN-INDUCED ARTHRITIS; MAJOON SURANJAN; METHOTREXATE; RHEUMATOID ARTHRITIS; TRADITIONAL MEDICINE; UNANI SYSTEM OF MEDICINE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CATTLE; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MEDICINE, UNANI; METHOTREXATE; PHYTOTHERAPY; RATS; RATS, WISTAR; RHEUMATOID FACTOR;

EID: 84888410312     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213498983     Document Type: Article

References (32)

1. David M,Weinblatt M.Rheumatoid arthritis.Lancet. 2001;358:903-11.
2. Jawaheer D,Thomson W,MacGregor AJ,Carthy D,Davidson J,Dyer PA,Silman AJ,Ollier WE."Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins.Arthritis Rheum. 1994;37:681-6.
3. Rathore B,Mahdi AA,Paul BN,Saxena PN,Das SK.Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis.J Clin Biochem Nutr. 2007;41:12-7.
4. Vaidya ADB,Devasagayam TPA.Current status of herbal drugs in India: an overview.J Clin Biochem Nutr. 2007;41:1-11.
5. Razi Z. Kitabul Hawi Fill Tibb. Vol 11. Urdu translation by CCRUM, Government of India. New Delhi, India: CCRMU, 2002:75-100.
6. Ahmad B,Akhtar J.Unani system of medicine.Phcog Rev. 2007;1:210-14.
7. Singh S,Nair V,Gupta YK.Anti-arthritic activity of Majoon suranjan (a polyherbal Unani formulation) in rat.Indian J Med Res. 2011;134:384-8.
8. Said HMHamdard Pharmacopoeia of Eastern Medicine. Indian Medical Science Series. New Delhi: Sri Satguru Publications; 1997:.
9. Reagan-Shaw S,Nihal M,Ahmad N.Dose translation from animal to human studies revisited.FASEB J. 2007;22:659-61.
10. Campo GM,Avenoso A,Campo S,Ferlazzo AM,Altavilla D,Calatroni A.Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats.Arthritis Res Ther. 2003;5:R122-31.
11. Holmdahl R,Carlsen S,Mikulowska A,Vestberg M,Brunsberg U,Hansson A,Sunduall M,Jansson L,Pettersson UHuman Genome Methods. Adolpho KW, ed. New York: CRC Press; 1998:215-215.
12. Shanahan JC,Moreland LW,Carter RH.Upcoming biologic agents for the treatment of rheumatic diseases.Curr Opin Rheumatol. 2003;15:226-36.
13. Rao J,Mihaliak K,Kroenke K,Bradley J,Tierney W,Weinberger M.Use of complementary therapies for arthritis among patients of rheumatologists.Ann Inter Med. 1999;131:409-16.
14. Gautam V, Raman RMV, Ashish K. Exporting Indian Healthcare (Export Potential of Ayurvedha and Siddha Products and Services). Road Beyond Boundaries (The Case of Selected Indian Healthcare Systems). Mumbai, India: Export-Import Bank of India; 2003:14-54.
15. Cheng CW,Bian ZX,Wu TX.Systematic review of Chinese herbal medicine for functional constipation.World J Gastroenterol. 2009;15:4886-95.
16. Hasan HA.Hemato-biochemical changes induced by fed intake of edible tiger nut (Cyerus esculentus) to senile rats.J Egypt Ger Soc Zool. 2005;48:217-36.
17. Bevaart L,Vervoordeldonk MJ,Tak PP.Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?.Arthritis Rheum. 2010;62:2192-205.
18. Ammar NM,Al-Okbi SY,Mohamed DA.Study of the anti-inflammatory activity of some medicinal edible plants growing in Egypt.J Islamic Acad Sci. 1997;10:113-22.
19. Ozbek H.The anti-inflammatory activity of the Foeniculum vulgare L. essential oil and investigation of its median lethal dose in rats and mice.Int J Pharmacol. 2005;1:329-31.
20. Saini AK,Goyal R,Gauttam VK,Kalia AN.Evaluation of anti-inflammatory potential of Ricinus communis Linn leaves extracts and its flavonoids content in Wistar rats.J Chem Pharm Res. 2010;2: 690-95.
21. Fazal SS,Singla RK.Review on the pharmacognostical & pharmacological characterization of Apium graveolens Linn.Indo Global J Pharmaceut Sci. 2012;2:36-42.
22. Vincent C,de Keyser F,Masson-Bessiere C,Sebbag M,Veys EM,Serre G.Anti-perinuclear factor compared with the so called 'antikeratin' antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.Ann Rheum Dis. 1999;58:42-8.
23. Goldbach-Mansky R,Lee J,McCoy A,Hoxworth J,Yarboro C,Smolen JS,Steiner G,Rosen A,Zhang C,Ménard HA,Zhou ZJ,Palosuo T,Van Venrooij WJ,Wilder RL,Klippel JH,Schumacher HR,El-Gabalawy HS.Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.Arthritis Res. 2000;2:236-43.
24. Schellekens GA,Visser H,de Jong BA,van den Hoogen FH,Hazes JM,Breedveld FC,van Venrooij WJ.The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.Arthritis Rheum. 2000;43:155-63.
25. De Rycke L,Peene I,Hoffman IE,Kruithof E,Union A,Meheus L,Lebeer K,Wyns B,Vincent C,Mielants H,Boullart L,Serre G,Veys EM,De Keyser F.Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.Ann Rheum Dis. 2004;63:1587-93.
26. Javed M,Khan JA,Siddiqui MM.Effect of Colchicum luteum baker in the management of rheumatoid arthritis.Indian J Tradit Know. 2005;4:421-3.
27. Lee SI,Hyun PM,Kim SH,Kim KS,Lee SK,Kim BS,Maeng PJ,Lim JS.Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.Arthritis Rheum. 2005;52:345-53.
28. Bang JS,Oh da H,Choi HM,Sur BJ,Lim SJ,Kim JY,Yang HI,Yoo MC,Hahm DH,Kim KS.Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.Arthritis Res Ther. 2009;11:R49-R57.
29. Subramaneyaan M, Yasmeen S, Arora VK, Tripathi AK, Banerjee BD, Ahmed RS. Safety evaluation and therapeutic efficacy of Habb-e-Asgand, a commonly used anti-rheumatic poly-herbal Unani formulation. Altern Ther Health Med 2012 (in press).
30. Calabrese LH.Molecular differences in anticytokines therapies.Clin Exp Rheumatol. 2003;21:241-8.
31. Louie SG,Park B,Yoon H.Biological response modifiers in the management of rheumatoid arthritis.Am J Health Syst Pharm. 2003;60:346-55.
32. Lubeck DP.A review of the direct costs of rheumatoid arthritis managed care versus fee-for-service settings.Pharmacoeconomics. 2001;19:811-8.